Endotherapy Devices Market – By Product Type (GI (Gastrointestinal) Devices & Accessories, ERCP (Endoscopic Retrograde Cholangio Pancreatography) Devices & Accessories, and Others), By Applications (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endotherapy, Gastrointestinal Endoscopy, and Others), By End-Users (Hospitals, Clinics, and Others), and By Region - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Endotherapy Devices Market is anticipated to grow from USD 3680.6 million in 2020 to USD 6653.8579 million by 2030, at a CAGR of 6.1% approx., during the forecast period. Endotherapy is a therapeutic process which encompasses the usage of endoscope to localize the intervention to a location in the body. Endoscope is a small, tube-like instrument used for endotherapy. Endotherapy devices are used to localise any type of abnormality within the body. These devices are mainly used to treat conditions such as abdominal pain, appendicitis, gallbladder disease, peptic ulcers, digestive tract bleeding, abnormal growth in the colon, and other abdominal & gastrointestinal conditions. The devices are placed within the body through natural openings or cavities or via incisions.

Market Segmentation:

On the basis of product type, the endotherapy devices market can be classified into Gastrointestinal (GI) devices & accessories, Endoscopic retrograde cholangio pancreatography (ERCP) devices & accessories, and others. Based on applications, the market can be segmented into bronchoscopy, arthroscopy, laparoscopy, urology endotherapy, gastrointestinal endoscopy, and others. According to end-users, the market is categorised into hospitals, clinics, and others. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.  

Market Dynamics and Factors:

The rise in the occurrence of diseases that require endotherapy procedures like cancer, gastrointestinal diseases, and others is one of the major factor driving the growth of the endotherapy device market. In addition to that growing preferences for minimally invasive procedures is anticipated to fuel the market growth. Minimal scarring, lower complications, reduced hospital stay, and rapid recovery are some other advantages of endoscopy which further drives the market growth of endotherapy devices. A surging baby boomer population coupled with high risk of targeted diseases; growing awareness about novel endotherapy devices; and adoption of highly innovative devices with ultra-high definition visualisation systems are other key factors propelling the market growth of endotherapy devices. However, high cost associated with endotherapy devices, and lack of skilled and technicians & physicians are certain restraining factors that are hampering the growth of the market. Additionally, infections caused due to endoscopic procedures because of improper sterilisation can further restrain the growth of the endotherapy devices in the global market.

Geographic Analysis:

North America is the dominating region in the global endotherapy devices market during the forecast period in terms of market share. Advanced healthcare systems; robust distribution channel for endotherapy devices; presence of a large number of manufacturers; and a growing geriatric population are the major factors attributing towards the market growth in the region. The Asia Pacific is expected to witness rapid growth during the forecast period. Increasing government expenditure on healthcare, rise in medical tourism, and investment by leading players in those regions are the key factors attributing towards this market growth.

Competitive Scenario:

The key players operating in the global endotherapy devices market are –

Johnson & Johnson, Hoya Corporation, Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Conmed Corporation Medtronic Plc. Fujifilm Holdings Corporation, Smith & Nephew, Siemens Healthcare, Advanced Sterilisation Products Services Inc.

Endotherapy Devices Market Report Scope